Featured series 
Tag: Ebola
-
Nation & World
CRISPR enzyme programmed to kill viruses in human cells
Researchers have turned a CRISPR enzyme into an antiviral that can be programmed to detect and destroy RNA-based viruses in human cells.
-
Nation & World
Inoculating against misinformation
A new survey by Harvard researchers shows that trust in leaders and institutions are at a low ebb in the eastern Democratic Republic of the Congo, highlighting the importance of gaining trust as part of the response to the growing Ebola epidemic there.
-
Nation & World
An indictment of Ebola response
An independent group of 20 international experts has issued a scathing analysis of the global response to the 2014-15 Ebola outbreak in West Africa.
-
Nation & World
New realities in care
Ashish Jha, director of the Harvard Global Health Institute, says the University has the talent, resources, and leadership to steer progress in improving health around the world.
-
Nation & World
Genetic sleuthing
An international team of researchers led by Harvard’s Pardis Sabeti have sequenced the genomes of hundreds of samples of Lassa fever and are using that data to try to unlock the virus’ secrets.
-
Nation & World
Sequencing Ebola’s secrets
A global team from Harvard University, the Broad Institute, the U.S. Centers for Disease Control, and other institutions sequenced more than 200 additional Ebola samples to capture the fullest picture yet of how the virus is transmitted and changes over a long-term outbreak.
-
Nation & World
‘Epidemics are optional’
Expanded medical care could greatly reduce Ebola fatalities, says Paul Farmer of Partners In Health.
-
Nation & World
Defending against the flu
Raphael Dolin of the Medical School discusses the evidence for hand washing, the timing of flu season, and who’s most vulnerable to serious complications.
-
Nation & World
Witness to anguish
Graduate School of Education alumna Jessi Hanson traveled to Liberia to help set up a program to provide art and play therapy to children held in isolation after their family members died from Ebola. She shared her experiences in Liberia — and now in self-quarantine in the United States — with the Gazette.
-
Nation & World
Behold the mammoth (maybe)
Harvard geneticist George Church discussed the future of genetic engineering, including possible technological applications allowing new treatment techniques. He saw the potential to improve human health, revolutionize pest management, and perhaps even bring back the mammoth and other extinct species.
-
Nation & World
A wake-up call on Ebola
The Dallas Ebola case was a black eye for emergency room workers who sent a Liberian man home even though they were told he had just arrived from the epidemic zone. But the case could act as a wake-up call for emergency workers around the country, panelists say.
-
Nation & World
Confronting Ebola
Three nonprofits with strong Harvard ties have joined forces at the front lines of the Ebola epidemic in West Africa.
-
Nation & World
Weapons for battling viruses
Bangladesh has used stepped-up surveillance, an understanding of transmission routes, and expert advice on cultural and traditional practices to devise interventions against Nipah, an Ebola-like virus with a high mortality rate.
-
Nation & World
Ebola’s ripple effects
The fight to end the Ebola epidemic is not just about saving lives, it’s also about heading off a potentially broader humanitarian crisis, according to a Harvard Kennedy School panel.
-
Nation & World
Ebola genomes sequenced
A team of researchers from the Broad Institute, Harvard University, and elsewhere has sequenced and analyzed dozens of Ebola virus genomes in the present outbreak. Their findings could have important implications for rapid field diagnostic tests.
-
Nation & World
Fewer clinics, less care
The protective gear needed to get Sierra Leone’s health clinics reopened, coupled with public education about the Ebola epidemic, are the greatest areas of need, according to a Harvard Fulbright Fellow and physician from Sierra Leone.
-
Nation & World
Understanding Ebola
Though the threat to the U.S. population from the Ebola outbreak in West Africa is low, the need in epidemic countries is great, says Michael VanRooyen, director of the Harvard Humanitarian Initiative.
-
Nation & World
Attacking Ebola
Two Harvard-led research teams report identifying a critical protein that Ebola virus exploits to cause deadly infections. The protein target is an essential element through which the virus enters living cells to cause disease.
